Abstract

Age-related neurological disorders AND include neurodegenerative diseases NDDs such as Alzheimer's disease AD and Parkinson's disease PD, which are the most prevalent types of dementia in the elderly. It also includes other illnesses such as migraine and epilepsy. ANDs are multifactorial, but aging is their major risk factor. The most frequent and vital pathological features of AND are oxidative stress, inflammation, and accumulation of misfolded proteins. As AND brain damage is a significant public health burden and its incidence is increasing, much has been done to overcome it. Pomegranate (Punica granatum L.) is one of the polyphenol-rich fruits that is widely mentioned in medical folklore. Pomegranate is commonly used to treat common disorders such as diarrhea, abdominal pain, wound healing, bleeding, dysentery, acidosis, microbial infections, infectious and noninfectious respiratory diseases, and neurological disorders. In the current review article, we aimed to summarize the data on the pharmacotherapeutic potentials of pomegranate in ANDs. Copyright © 2022 Emami Kazemabad, Asgari Toni, Tizro, Dadkhah, Amani, Akhavan Rezayat, Sheikh, Mohammadi, Alijanzadeh, Alimohammadi, Shahrokhi, Erabi, Noroozi, Karimi, Honari and Deravi.